EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,472,084 | -29.9% | 445,139 | -26.1% | 0.00% | 0.0% |
| Q2 2023 | $4,955,974 | -3.2% | 602,184 | -14.7% | 0.00% | 0.0% |
| Q1 2023 | $5,118,907 | -36.0% | 706,056 | -21.7% | 0.00% | -50.0% |
| Q4 2022 | $8,002,062 | -41.4% | 902,149 | -19.1% | 0.00% | -33.3% |
| Q3 2022 | $13,657,000 | +46.6% | 1,115,723 | +41.6% | 0.00% | +50.0% |
| Q2 2022 | $9,319,000 | -22.9% | 787,720 | +23.9% | 0.00% | -33.3% |
| Q1 2022 | $12,088,000 | -53.8% | 635,549 | -35.5% | 0.00% | -40.0% |
| Q4 2021 | $26,155,000 | -54.3% | 985,154 | -29.3% | 0.01% | -58.3% |
| Q3 2021 | $57,251,000 | +24.7% | 1,393,629 | +71.9% | 0.01% | +20.0% |
| Q2 2021 | $45,907,000 | +20.4% | 810,513 | -10.7% | 0.01% | 0.0% |
| Q1 2021 | $38,135,000 | -47.1% | 907,979 | -11.7% | 0.01% | -44.4% |
| Q4 2020 | $72,123,000 | +159.7% | 1,028,692 | +4.0% | 0.02% | +125.0% |
| Q3 2020 | $27,767,000 | +21.4% | 989,558 | +28.0% | 0.01% | +14.3% |
| Q2 2020 | $22,868,000 | +74.9% | 773,085 | +17.2% | 0.01% | +40.0% |
| Q1 2020 | $13,076,000 | -38.9% | 659,408 | -8.8% | 0.01% | 0.0% |
| Q4 2019 | $21,398,000 | +39.3% | 722,661 | +7.0% | 0.01% | +25.0% |
| Q3 2019 | $15,359,000 | -22.3% | 675,418 | -15.5% | 0.00% | -33.3% |
| Q2 2019 | $19,773,000 | +21.7% | 799,258 | +20.3% | 0.01% | +20.0% |
| Q1 2019 | $16,248,000 | +8.5% | 664,531 | +0.9% | 0.01% | 0.0% |
| Q4 2018 | $14,981,000 | +1.9% | 658,498 | +42.5% | 0.01% | +25.0% |
| Q3 2018 | $14,704,000 | +22.2% | 462,076 | +37.6% | 0.00% | +33.3% |
| Q2 2018 | $12,032,000 | +5.9% | 335,812 | -2.1% | 0.00% | 0.0% |
| Q1 2018 | $11,367,000 | +31.0% | 342,924 | +21.5% | 0.00% | +50.0% |
| Q4 2017 | $8,674,000 | -13.6% | 282,286 | -32.5% | 0.00% | 0.0% |
| Q3 2017 | $10,037,000 | +73.3% | 418,086 | +21.1% | 0.00% | +100.0% |
| Q2 2017 | $5,793,000 | +651.4% | 345,266 | +899.1% | 0.00% | – |
| Q1 2017 | $771,000 | +60.3% | 34,559 | +16.7% | 0.00% | – |
| Q4 2016 | $481,000 | -17.9% | 29,614 | -32.0% | 0.00% | – |
| Q3 2016 | $586,000 | -52.6% | 43,531 | -14.0% | 0.00% | – |
| Q2 2016 | $1,236,000 | -48.6% | 50,641 | -27.3% | 0.00% | -100.0% |
| Q1 2016 | $2,405,000 | – | 69,641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |